https://www.sightsciences.com/us/newsroom/ 2026-04-29T20:26:54+00:00 https://www.sightsciences.com/us/sight-sciences-receives-full-investigational-device-exemption-ide-approval-from-the-us-fda-to-initiate-the-visco360-versus-slt-glaucoma-trial/ 2016-07-26T17:14:48+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-closing-of-its-7mm-series-b-financing-led-by-hicks-equity-partners/ 2016-09-17T17:14:11+00:00 https://www.sightsciences.com/us/sight-sciences-announces-expanding-management-team-of-seasoned-medical-device-experts/ 2017-02-15T17:13:12+00:00 https://www.sightsciences.com/us/sight-sciences-secures-10mm-in-oversubscribed-series-c-financing/ 2017-10-09T17:12:27+00:00 https://www.sightsciences.com/us/sight-sciences-names-jesse-selnick-chief-financial-officer/ 2018-03-14T17:10:40+00:00 https://www.sightsciences.com/us/reay-h-brown-m-d-joins-sight-sciences-as-chief-medical-officer/ 2018-10-23T17:07:21+00:00 https://www.sightsciences.com/us/sight-sciences-hires-leading-industry-executives-to-drive-continued-growth/ 2019-08-07T16:59:41+00:00 https://www.sightsciences.com/us/sight-sciences-raises-56m-of-growth-capital-to-lead-the-development-of-the-standalone-migs-market-and-procedure-based-dry-eye-market/ 2019-09-04T16:57:57+00:00 https://www.sightsciences.com/us/sight-sciences-appoints-erica-rogers-to-its-board-of-directors/ 2019-12-09T18:54:07+00:00 https://www.sightsciences.com/us/event-las-vegas-nv/ 2020-02-26T22:51:34+00:00 https://www.sightsciences.com/us/event-osn-ny/ 2020-02-26T22:59:38+00:00 https://www.sightsciences.com/us/sight-sciences-announces-30-million-financing-led-by-d1-capital-partners/ 2020-03-18T16:25:53+00:00 https://www.sightsciences.com/us/sight-sciences-announces-publication-of-historical-review-of-canal-surgery-in-the-glaucoma-issue-of-current-opinion-in-ophthalmology/ 2020-03-30T20:00:31+00:00 https://www.sightsciences.com/us/sight-sciences-strengthens-its-leadership-team-with-chief-operating-officer-and-general-counsel-hires/ 2020-06-25T14:29:55+00:00 https://www.sightsciences.com/us/sight-sciences-appoints-donald-j-zurbay-to-companys-board-of-directors/ 2020-07-14T14:46:36+00:00 https://www.sightsciences.com/us/sight-sciences-announces-substantial-crossover-raise/ 2020-12-01T15:50:53+00:00 https://www.sightsciences.com/us/glaucoma-360/ 2020-12-21T17:59:23+00:00 https://www.sightsciences.com/us/glaucoma-360-2/ 2020-12-21T18:03:35+00:00 https://www.sightsciences.com/us/american-glaucoma-society/ 2020-12-21T18:04:35+00:00 https://www.sightsciences.com/us/event-hawaiian-eye-and-retina/ 2021-03-30T22:47:57+00:00 https://www.sightsciences.com/us/event-southern-council-of-optometry-seco/ 2021-03-30T22:56:21+00:00 https://www.sightsciences.com/us/event-kiawah-eye/ 2021-03-30T22:59:13+00:00 https://www.sightsciences.com/us/event-cataract-surgery-telling-it-like-it-is-cstilii-2/ 2021-03-30T23:05:50+00:00 https://www.sightsciences.com/us/event-world-glaucoma-congress-wgc/ 2021-03-30T23:26:43+00:00 https://www.sightsciences.com/us/event-american-european-congress-of-ophthalmic-surgery-summer-symposium-aecos-summer/ 2021-03-30T23:30:36+00:00 https://www.sightsciences.com/us/event-women-in-ophthalmology-wio-2/ 2021-03-30T23:43:44+00:00 https://www.sightsciences.com/us/event-american-academy-of-ophthalmology-aaoph-2/ 2021-03-30T23:51:06+00:00 https://www.sightsciences.com/us/event-vision-expo-east-vee-2/ 2021-03-31T04:16:13+00:00 https://www.sightsciences.com/us/event-american-optometric-association-aoa-2/ 2021-03-31T04:18:50+00:00 https://www.sightsciences.com/us/event-vision-source-exchange-vse-2/ 2021-03-31T04:21:16+00:00 https://www.sightsciences.com/us/event-vision-expo-west-vew-2/ 2021-03-31T04:24:23+00:00 https://www.sightsciences.com/us/event-american-academy-of-optometry-aaopt-2/ 2021-03-31T04:30:57+00:00 https://www.sightsciences.com/us/sight-sciences-announces-pricing-of-initial-public-offering/ 2021-07-17T20:08:37+00:00 https://www.sightsciences.com/us/sight-sciences-announces-closing-of-initial-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares/ 2021-07-23T15:44:45+00:00 https://www.sightsciences.com/us/sight-sciences-announces-multiple-presentations-at-the-2021-american-society-of-cataract-and-refractive-surgery-annual-meeting/ 2021-07-23T15:46:06+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-second-quarter-2021-financial-results-on-august-12-2021/ 2021-08-02T21:10:26+00:00 https://www.sightsciences.com/us/sight-sciences-reports-second-quarter-2021-financial-results/ 2021-08-12T20:12:31+00:00 https://www.sightsciences.com/us/sight-sciences-pioneering-the-development-of-the-standalone-migs-market/ 2021-08-24T13:29:18+00:00 https://www.sightsciences.com/us/sight-sciences-to-participate-in-the-morgan-stanley-global-healthcare-conference/ 2021-08-26T20:13:48+00:00 https://www.sightsciences.com/us/sight-sciences-files-lawsuit-against-ivantis-for-patent-infringement/ 2021-09-16T23:39:35+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-third-quarter-2021-financial-results-on-november-10-2021/ 2021-10-27T20:18:16+00:00 https://www.sightsciences.com/us/sight-sciences-announces-fda-authorization-for-the-precision-trial-a-groundbreaking-three-arm-randomized-controlled-ide-trial/ 2021-11-10T21:18:02+00:00 https://www.sightsciences.com/us/sight-sciences-reports-third-quarter-2021-financial-results/ 2021-11-11T01:15:06+00:00 https://www.sightsciences.com/us/microinvasive-glaucoma-surgery-with-the-omni-surgical-system-is-associated-with-diminished-diurnal-iop-fluctuations-a-significant-independent-risk-factor-for-glaucoma-progression/ 2021-11-18T21:19:48+00:00 https://www.sightsciences.com/us/sight-sciences-to-participate-in-the-upcoming-piper-sandler-annual-healthcare-conference/ 2021-11-18T22:12:03+00:00 https://www.sightsciences.com/us/sight-sciences-launches-dont-wait-for-too-late-awareness-campaign-for-glaucoma/ 2022-02-17T16:19:49+00:00 https://www.sightsciences.com/us/sight-sciences-announces-multiple-presentations-at-the-2022-american-glaucoma-society-annual-meeting/ 2022-03-02T16:44:26+00:00 https://www.sightsciences.com/us/sight-sciences-announces-appointment-of-brenda-becker-to-board-of-directors/ 2022-03-16T14:45:30+00:00 https://www.sightsciences.com/us/sight-sciences-announces-first-patient-treated-in-trident-european-trial-to-evaluate-the-omni-surgical-system-in-pseudophakic-eyes-with-open-angle-glaucoma/ 2022-03-24T20:43:55+00:00 https://www.sightsciences.com/us/sight-sciences-reports-fourth-quarter-and-full-year-2021-financial-results/ 2022-03-24T21:52:29+00:00 https://www.sightsciences.com/us/sight-sciences-announces-multiple-presentations-and-event-at-the-2022-american-society-of-cataract-and-refractive-surgery-annual-meeting/ 2022-04-20T21:27:51+00:00 https://www.sightsciences.com/us/sight-sciences-to-present-at-the-upcoming-bank-of-america-healthcare-conference/ 2022-04-29T16:28:54+00:00 https://www.sightsciences.com/us/sight-sciences-reports-first-quarter-2022-financial-results/ 2022-05-10T23:04:41+00:00 https://www.sightsciences.com/us/gemini-12-month-outcomes/ 2022-05-31T14:50:22+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-appointment-of-tamara-fountain-m-d-to-its-board-of-directors/ 2022-07-19T21:17:05+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-second-quarter-2022-financial-results-on-august-11-2022/ 2022-07-28T15:45:01+00:00 https://www.sightsciences.com/us/sight-sciences-announces-long-term-safety-and-effectiveness/ 2022-08-16T14:30:06+00:00 https://www.sightsciences.com/us/sight-sciences-introduces-the-sion-surgical-instrument-the-first-bladeless-device-used-in-goniotomy/ 2022-08-23T14:23:26+00:00 https://www.sightsciences.com/us/sight-sciences-to-present-at-the-upcoming-morgan-stanley-global-healthcare-conference/ 2022-09-02T14:16:08+00:00 https://www.sightsciences.com/us/sahara-enrollment-completion/ 2022-09-13T14:35:00+00:00 https://www.sightsciences.com/us/sight-sciences-omni-standalone-at-aao/ 2022-09-28T15:04:06+00:00 https://www.sightsciences.com/us/sight-sciences-announces-publication-of-data/ 2022-09-29T15:19:23+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022/ 2022-10-20T21:35:26+00:00 https://www.sightsciences.com/us/sight-sciences-reports-third-quarter-2022-financial-results/ 2022-11-10T22:08:49+00:00 https://www.sightsciences.com/us/sight-sciences-to-present-at-the-upcoming-piper-sandler-34th-annual-healthcare-conference/ 2022-11-22T17:50:11+00:00 https://www.sightsciences.com/us/sight-sciences-to-present-at-upcoming-citi-2023-conference/ 2023-02-22T22:04:40+00:00 https://www.sightsciences.com/us/fourth-quarter-and-full-year-2022-financial-results/ 2023-03-13T22:22:43+00:00 https://www.sightsciences.com/us/sight-sciences-defeats-invalidity-challenges/ 2023-03-31T21:15:32+00:00 https://www.sightsciences.com/us/sight-sciences-appoints-ali-bauerlein-as-chief-financial-officer/ 2023-04-03T20:17:57+00:00 https://www.sightsciences.com/us/sight-sciences-to-host-surgical-glaucoma-investor-symposium/ 2023-04-13T21:39:41+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-first-quarter-2023-financial-results-on-may-4-2023/ 2023-04-20T22:21:03+00:00 https://www.sightsciences.com/us/sight-sciences-to-present-at-the-upcoming-bank-of-america-securities-2023-health-care-conference/ 2023-04-26T20:20:35+00:00 https://www.sightsciences.com/us/sight-sciences-glaucoma-and-dry-eye-technologies-to-be-featured-in-multiple-clinical-presentations-at-the-2023-american-society-of-cataract-and-refractive-surgery-ascrs-annual-meeting/ 2023-05-01T20:03:25+00:00 https://www.sightsciences.com/us/sight-sciences-reports-first-quarter-2023-financial-results-and-reaffirms-guidance-for-full-year-2023/ 2023-05-04T21:29:04+00:00 https://www.sightsciences.com/us/sight-sciences-announces-12-month-results-from-american-academy-of-ophthalmology-iris/ 2023-05-06T17:22:47+00:00 https://www.sightsciences.com/us/sight-sciences-announces-addition-of-new-director-catherine-mazzacco/ 2023-06-09T20:51:57+00:00 https://www.sightsciences.com/us/cigna-expands-coverage-of-glaucoma-surgical-procedures-to-include-canaloplasty-and-goniotomy-trabeculotomy/ 2023-06-21T14:06:40+00:00 https://www.sightsciences.com/us/us/wp-content/uploads/sites/4/2023/06/omni-ergo-series.png https://www.sightsciences.com/us/sight-sciences-announces-positive-results-and-primary-endpoint-successfully-met-in-sahara/ 2023-07-20T17:05:39+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-second-quarter-2023-financial-results-on-august-3-2023/ 2023-07-20T22:08:46+00:00 https://www.sightsciences.com/us/sight-sciences-reports-second-quarter-2023-financial-results-and-reaffirms-guidance-for-full-year-2023/ 2023-08-03T21:35:44+00:00 https://www.sightsciences.com/us/ssi-presenting-at-morgan-stanley-21st-annual-global-healthcare-conference/ 2023-08-30T20:27:49+00:00 https://www.sightsciences.com/us/sight-sciences-appoints-matt-link-as-chief-commercial-officer/ 2023-09-11T20:33:13+00:00 https://www.sightsciences.com/us/sight-sciences-updates-revenue-guidance-for-2023/ 2023-09-11T20:40:48+00:00 https://www.sightsciences.com/us/sight-sciences-announces-new-large-scale-migs-data-from-41st-congress-of-escrs/ 2023-10-03T18:50:44+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-third-quarter-2023-financial-results-on-november-7-2023/ 2023-10-24T21:51:44+00:00 https://www.sightsciences.com/us/sight-sciences-reports-third-quarter-2023-financial-results-and-withdraws-guidance-for-full-year-2023/ 2023-11-08T02:53:01+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-acceptance-for-publication-of-gemini-2/ 2023-12-08T17:57:13+00:00 https://www.sightsciences.com/us/sight-sciences-omni-surgical-system-to-be-featured-in-multiple-presentations-at-the-2022-european-society-of-cataract-and-refractive-surgery-annual-meeting/ 2024-05-27T06:00:26+00:00 https://www.sightsciences.com/us/sight-sciences-receives-fda-510k-clearance-of-the-tearcare-system-for-treatment-of-meibomian-gland-dysfunction-mgd-the-leading-cause-of-dry-eye-disease/ 2024-05-27T06:19:08+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital/ 2024-05-27T06:48:17+00:00 https://www.sightsciences.com/us/sight-sciences-announces-european-launch-of-the-ergo-series-of-the-omni-surgical-system-at-the-escrs-winter-meeting/ 2024-05-28T09:38:25+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-first-quarter-financial-results-on-may-2-2024/ 2024-05-28T09:40:56+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-fourth-quarter-and-full-year-2023-financial-results-on-march-7-2024/ 2024-05-28T09:41:04+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2021/11/sightsciences-logo.svg https://www.sightsciences.com/us/publication-of-omni-standalone-effectiveness/ 2024-05-28T09:45:44+00:00 https://www.sightsciences.com/us/sight-sciences-announces-1000th-tearcare-customer-installation/ 2024-05-28T09:45:49+00:00 https://www.sightsciences.com/us/sight-sciences-announces-preliminary-unaudited-fourth-quarter-and-full-year-2023-financial-highlights/ 2024-05-28T09:45:55+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-publication-of-successful-results-of-the-sahara-randomized-controlled-clinical-trial/ 2024-05-28T09:46:06+00:00 https://www.sightsciences.com/us/sight-sciences-announces-withdrawal-of-final-lcds-on-micro-invasive-glaucoma-surgery-from-five-medicare-administrative-contractors/ 2024-05-28T09:46:11+00:00 https://www.sightsciences.com/us/sight-sciences-launches-the-ergo-series-of-the-omni-surgical-system/ 2024-05-28T09:46:17+00:00 https://www.sightsciences.com/us/sight-sciences-two-year-multicenter-study-results/ 2024-05-28T09:46:57+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-publication-of-large-scale-real-world-migs/ 2024-05-28T10:03:41+00:00 https://www.sightsciences.com/us/improvements-in-signs-and-symptoms-of-dry-eye-disease/ 2024-05-31T08:20:47+00:00 https://www.sightsciences.com/us/sight-sciences-reports-fourth-quarter-and-full-year-2023-financial-results-and-initiates-full-year-2024-financial-guidance/ 2024-05-31T08:21:59+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-release-of-its-first-sustainability-report/ 2024-06-10T20:29:14+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-results-of-the-three-year-prospective-gemini-trial-and-the-cross-over-phase-of-the-sahara-rct-at-the-2024-ascrs/ 2024-07-10T13:08:54+00:00 https://www.sightsciences.com/us/sight-sciences-announces-presentation-of-successful-phase-i-results-of-the-sahara-randomized-controlled-clinical-trial-comparing-tearcare-to-restasis/ 2024-07-10T14:43:34+00:00 https://www.sightsciences.com/us/sight-sciences-reports-second-quarter-2022-financial-results/ 2024-07-17T08:10:28+00:00 https://www.sightsciences.com/us/sight-sciences-announces-publication-of-a-new-analysis-from-the-romeo-study-showing-meaningful-pressure-and-medication-reductions-achieved-with-omni-across-mild-moderate-and-advanced-glaucoma/ 2024-07-17T08:18:06+00:00 https://www.sightsciences.com/us/sight-sciences-announces-successful-34-million-patent-infringement-verdict-against-alcon-and-its-hydrus-microstent-for-microinvasive-glaucoma-surgery/ 2024-07-17T08:18:34+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-publication-of-twelve-month-results-of-the-sahara-rct-demonstrating-improved-signs-and-symptoms-of-dry-eye-disease-for-tearcare-patients-crossed-over-from-restasis/ 2024-07-17T08:19:34+00:00 https://www.sightsciences.com/us/sight-sciences-reports-first-quarter-2024-financial-results-and-reaffirms-full-year-2024-financial-guidance/ 2024-07-17T08:20:35+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2024/04/SISC_RTS_Logo_Primary_RGB_P1-1200.png https://www.sightsciences.com/us/sight-sciences-to-host-sahara-6-month-rct-results-reception-at-the-american-academy-of-ophthalmology-2023/ 2024-07-17T08:21:02+00:00 https://www.sightsciences.com/us/sight-sciences-to-present-at-the-upcoming-bank-of-america-healthcare-conference-2/ 2024-07-17T08:21:21+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2024/04/SISC_RTS_Logo_Primary_RGB_P1-1200.png https://www.sightsciences.com/us/sight-sciences-to-present-at-the-upcoming-23rd-annual-needham-healthcare-conference/ 2024-07-17T08:22:19+00:00 https://www.sightsciences.com/us/sight-sciences-to-report-second-quarter-financial-results-on-august-1-2024/ 2024-08-15T07:54:06+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2024/08/a7fd72f065297c8ce21e0592c428cfca.jpg https://www.sightsciences.com/us/sight-sciences-to-debut-omni-edge-surgical-system-at-the-2025-ascrs-annual-meeting-expanding-the-omni-product-portfolio/ 2025-04-22T20:00:13+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/OMNI-Edge-Photo-7-scaled.jpg https://www.sightsciences.com/us/sight-sciences-appoints-gary-burbach-to-its-board-of-directors/ 2025-04-22T20:59:43+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-announces-the-release-of-its-sustainability-report/ 2025-04-23T20:19:25+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-report-first-quarter-2025-financial-results-on-may-8-2025/ 2025-04-24T22:38:03+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-reports-first-quarter-2025-financial-results-and-reaffirms-full-year-2025-revenue-guidance/ 2025-05-08T20:23:24+00:00 https://www.sightsciences.com/us/sight-sciences-to-present-at-the-stifel-2025-virtual-ophthalmology-forum-on-may-27th/ 2025-05-14T20:12:40+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-report-second-quarter-2025-financial-results-on-august-7-2025/ 2025-07-25T21:45:06+00:00 https://www.sightsciences.com/us/sight-sciences-announces-the-publication-of-the-24-month-results-of-the-sahara-rct-demonstrating-the-durability-of-the-tearcare-procedure-for-the-treatment-of-dry-eye-disease/ 2025-07-29T17:57:31+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-announces-the-results-of-a-cost-utility-analysis-demonstrating-cost-savings-and-greater-health-utility-with-the-tearcare-system-compared-to-cyclosporine-0-05-for-treating-meibomia/ 2025-07-30T14:32:15+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/07/SISC_TearCare_1200x628.jpg https://www.sightsciences.com/us/sight-sciences-reports-second-quarter-2025-financial-results-and-raises-full-year-2025-revenue-guidance/ 2025-08-07T20:34:15+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-present-at-the-upcoming-morgan-stanley-global-healthcare-conference-2/ 2025-08-26T23:58:05+00:00 https://www.sightsciences.com/us/sight-sciences-announces-recognition-of-the-tearcare-system-in-tfos-dews-iii-global-dry-eye-guidelines-published-in-ajo/ 2025-09-02T20:18:20+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-announces-the-omni-surgical-system-to-be-included-in-unitedhealthcares-expanded-coverage-of-glaucoma-surgical-treatments/ 2025-09-09T19:05:04+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-announces-publication-of-a-systematic-literature-review-and-meta-analysis-showing-omni-surgical-system-achieves-clinically-significant-long-term-reductions-in-iop-and-medication/ 2025-09-17T17:26:29+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-announces-novitas-and-first-coast-service-options-fee-schedule/ 2025-10-17T12:33:03+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-report-third-quarter-2025-financial-results-on-november-6-2025/ 2025-10-23T20:35:23+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-present-at-two-upcoming-investor-conferences/ 2025-11-04T22:06:39+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-appoints-ali-bauerlein-as-chief-operating-officer-and-jim-rodberg-as-chief-financial-officer/ 2025-11-06T23:36:47+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-reports-third-quarter-2025-financial-results-and-raises-full-year-2025-revenue-guidance/ 2025-11-06T23:39:12+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/new-peer-reviewed-publications-highlight-effectiveness-of-omni-surgical-system-with-trusync-technology-in-reducing-iop-and-medication-usage-in-cataract-combination-procedures-standalon/ 2025-11-11T15:36:40+00:00 https://www.sightsciences.com/us/sight-sciences-announces-preliminary-unaudited-fourth-quarter-and-full-year-2025-financial-highlights/ 2026-01-13T18:23:05+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-4-2026/ 2026-02-18T21:55:29+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-reports-fourth-quarter-and-full-year-2025-financial-results-and-initiates-full-year-2026-financial-guidance/ 2026-03-04T21:36:12+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-secures-order-on-post-trial-motions-that-preserves-the-jurys-verdict-and-awards-monetary-damages-to-sight-sciences-against-alcon-and-its-hydrus-microstent/ 2026-03-30T20:22:52+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-present-at-the-25th-annual-needham-healthcare-conference-on-april-13th/ 2026-03-30T21:00:29+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-interventional-technologies-for-glaucoma-and-dry-eye-disease-to-be-featured-in-multiple-clinical-presentations-at-the-2026-american-society-of-cataract-and-refractive-surgery/ 2026-04-01T20:30:20+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-report-first-quarter-2026-financial-results-on-may-6-2026/ 2026-04-21T21:13:51+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-announces-the-release-of-its-sustainability-report-2026/ 2026-04-22T22:12:25+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png https://www.sightsciences.com/us/sight-sciences-to-present-at-two-upcoming-investor-conferences-2026/ 2026-04-29T20:26:54+00:00 https://www.sightsciences.com/us/wp-content/uploads/sites/4/2025/04/featured_image_1200_630.png